Document Preview Unavailable

The immunomodulatory properties of the HDAC6 inhibitor ACY241 supports robust anti-tumor response in NSCLC when coupled with the chemotherapy drug Oxaliplatin

Bag, Arup; Schultz, Andrew; Bhimani, Saloni; Dominguez, William; Cen, Ling; et al.  bioRxiv, Oct 2, 2021.

You might have access to this document